Related Experiment Video
Updated: Apr 27, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
An update on RNA interference-mediated gene silencing in cancer therapy
1Soochow University, College of Pharmaceutical Sciences, Department of Pharmacology , Suzhou, Jiangsu , China zhangyi@suda.edu.cn.
Introduction:
Based on our previous review, this article presents the new progress in RNA interference (RNAi)-mediated gene silencing in cancer therapy, and reviews the hurdles and how they might be overcome.
Areas Covered:
RNAi-mediated gene silencing approaches have been demonstrated in humans, and ongoing clinical trials hold promise for treating cancer or providing alternatives to traditional chemotherapies. Here we describe the broad range of approaches to achieve targeted gene silencing for cancer therapy, discuss the progress made in developing RNAi as therapeutics for cancer and highlight challenges and emerging solutions associated with its clinical development.
Expert Opinion:
Although the field of RNAi-based cancer therapy is still an emerging one, we have yet to get solutions for overcoming all obstacles associated with its clinical development. The current rapid advances in development of new targeted delivery strategies and noninvasive imaging methods will be big steps to explore RNAi as a new and potent clinical modality in humans.
Insights
RNA interference (RNAi) gene silencing shows promise for cancer therapy, with ongoing clinical trials. Advances in targeted delivery and imaging are key to overcoming challenges for its clinical use.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- RNA interference (RNAi) is a gene silencing mechanism with therapeutic potential.
- Previous reviews have established the foundation for RNAi in cancer research.
Purpose of the Study:
- To present recent advancements in RNAi-mediated gene silencing for cancer therapy.
- To review existing hurdles and potential solutions for clinical RNAi development.
Main Methods:
- Review of current RNAi-mediated gene silencing approaches for cancer.
- Discussion of progress in developing RNAi therapeutics.
- Highlighting challenges and emerging solutions in clinical development.
Main Results:
- RNAi-mediated gene silencing has been demonstrated in human trials.
- Ongoing clinical trials indicate promise for cancer treatment and chemotherapy alternatives.
Conclusions:
- RNAi-based cancer therapy is an emerging field with remaining clinical development obstacles.
- Progress in targeted delivery and noninvasive imaging are crucial for advancing RNAi as a clinical modality.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
09:18TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
Published on: June 2, 2016
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs
MicroRNAs